Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Terminated Phase 1 Trials for Eltrombopag (DB06210)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01550185Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid LeukemiaTreatment